CAHIC has obtained the clinical trial approval for the African swine fever subunit vaccine
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, CAHIC announced that it has recently received the clinical trial approval for the African Swine Fever subunit vaccine issued by the Ministry of Agriculture and Rural Affairs (Approval No.: 2025058). The African Swine Fever subunit vaccine is used to prevent African Swine Fever virus infection. The company collaborated with research institutions to develop this vaccine in 2023. As of now, the total research and development investment for this product is approximately RMB 46.2446 million
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments